Registration is now open for the National Home Infusion Association’s 2026 Annual Conference (NHIA 2026), to be held April 18-22, 2026, at the Gaylord Rockies Resort and Convention Center in Denver, CO.
After receiving feedback from members, the association submitted comments to CMS on the proposed rule that includes implementation of the Joe Fiandra Access to Home Infusion Act as well as steps in the agency’s continued focus on fraud and abuse. Read the comments.
NHIA commends CMS for listening to stakeholders and deciding not to move forward at this time with the proposed changes to HCPCS codes and billing units for immune globulin products.
The National Home Infusion Foundation’s Wellness Challenge is returning this September, and we’re excited to invite your organization to sponsor a team and make a meaningful impact on our industry!
This proposal to modify the criteria for the use of an infusion pump should not be viewed as a solution to the broader access challenges facing Medicare beneficiaries who could safely receive infusion therapy at home.
NHIA submitted comments to CMS on a new proposed rule on interoperability and prior authorization for drugs. While NHIA is mostly supportive of standardizing prior authorization (PA) processes for Medicare-covered drugs, it wants CMS to know that home infusion may not fit neatly into processes designed for medical and pharmacy benefits.
NHIA strongly opposes CMS’s proposed HCPCS coding and billing unit changes for immune globulin products, arguing that the changes would create significant administrative, operational, reimbursement, and patient care challenges without providing meaningful clinical or financial benefit.
The National Home Infusion Foundation (NHIF) welcomes the 2026-2027 Board of Directors.
Last week concluded the 2026 National Home Infusion Association Annual Conference (NHIA 2026), which convened the largest gathering dedicated to the home and alternate site infusion industry in Denver, Colorado.
The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).
The National Home Infusion Foundation (NHIF) announces the winner and honorable mention for its Outstanding Abstract Achievement Award for 2026.
The National Home Infusion Association has announced the finalists for its 2026 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
The National Home Infusion Association (NHIA) is pleased to announce the 2026 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
The National Home Infusion Foundation (NHIF) is proud to announce Barbara Petroff, MS, RPh, BCSCP, CAC, CSPP, IgCP, FNHIA, FASHP as the recipient of the 2026 Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Melissa Leone, RN, BSN, FNHIA has been selected as the recipient of the 2026 Gene Graves Lifetime Achievement Award.
The National Home Infusion Association (NHIA) is proud to announce its 2026-2027 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization.
The National Home Infusion Association (NHIA) is releasing Infusion Industry Trends, the latest assessment of the home and alternate site infusion industry’s market position. Based on claims data from a 3-year timeframe, this focused analysis shows how the industry is evolving across therapy categories and payor environments.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2026. The authors of the following 4 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
The National Home Infusion Association (NHIA) has received clarification from CMS regarding enrollment options for home infusion pharmacies under the current nationwide DMEPOS enrollment moratorium.
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to certain health care provider-administered drugs if an infusion pump is required for administration. Passage of H.R. 4993, the Joe Fiandra Access to Home Infusion Act, reflects Congress’ recognition of the strong patient interest—including among individuals with rare diseases—in home infusion access.
National Home Infusion Association (NHIA) President and CEO Connie Sullivan testified today before the House Energy and Commerce Committee Subcommittee on Health in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172). The hearing marked a major milestone for the legislation, with Members from both parties emphasizing the need to strengthen Medicare and remove barriers that keep seniors from receiving clinically appropriate infusion care at home.
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for the NHIA member organization. Seats are open to provider members and are assigned at the organization level. Two seats are currently available for hospital providers (a provider that is wholly owned and operated as part of an acute care system).
The National Home Infusion Association (NHIA) and Inovalon are pleased to announce the addition of Inovalon to NHIA’s Future of Infusion Advisory Council (FIAC).
The National Home Infusion Association (NHIA) today announced growing bipartisan momentum for the Preserving Patient Access to Home Infusion Act, with ten new cosponsors signing onto the bill in the wake of NHIA’s Advocacy in Action Day.
NHIA is seeking public feedback on the draft Infusion Practice Standard: Pharmacist Documentation – Initial Assessment and Plan of Care. This standard was developed in response to a growing need for clear, consistent guidance on pharmacist documentation practices within the home and alternate-site.
The National Home Infusion Association (NHIA) today held its annual Advocacy in Action Day, during which association members and patients met with Members of Congress and their staff to advocate for a fix to the Medicare home infusion coverage gap. Over the course of the event, NHIA members held more than 130 meetings in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172 / S. 1058).
Registration is now open for the National Home Infusion Association’s 2026 Annual Conference (NHIA 2026), to be held April 18-22, 2026, at the Gaylord Rockies Resort and Convention Center in Denver, CO.
NHIA released a new white paper, “Trends in Home Enteral Nutrition—The Impacts of Competitive Bidding on Access and Quality,” which documents the declining payment structure for clinical services needed to support patients on home enteral nutrition.
NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications.
The Joe Fiandra Access to Home Infusion Act (H.R. 5397) was first introduced in the House of Representatives in September of 2023, and re-introduced on August 19, 2025 by Rep. Brian Fitzpatrick (PA-01). The bill mirrors a 2020 proposed rule from the Centers for Medicare and Medicaid Services (CMS) to modify the DMEPOS external infusion pump benefit.
The National Home Infusion Association (NHIA) has released a white paper examining the economic challenges facing home parenteral nutrition (HPN) services. The report, “Ensuring Sustainable Access to Home Parenteral Nutrition (PN): The Cost Crisis and Path Forward,” documents cost trends and reimbursement patterns affecting this therapy.
The National Home Infusion Foundation’s Wellness Challenge is returning this September, and we’re excited to invite your organization to sponsor a team and make a meaningful impact on our industry!
The National Home Infusion Association (NHIA) and WeInfuse are pleased to announce the addition of WeInfuse to NHIA’s Future of Infusion Advisory Council (FIAC).
NHIA applauds Secretary Kennedy’s recent statement in support of improving access to home infusion services for Medicare beneficiaries. We agree with his sentiment that commonsense reforms to Medicare – like home infusion – will save taxpayer dollars while improving access to care, especially for rural and elderly patients. We stand ready to work with the Secretary and HHS to remedy the current lack of coverage for home infusion therapies.
